Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 3, 2011, Pages 320-325

  Hu, Yurong ^a   Shen, Yingying ^a   Ji, Baofang ^a   Yin, Shasha ^a   Ren, Xueling ^a   Chen, Tingting ^a   Ma, Yue ^a   Zhang, Zhenzhong ^a   Zhang, Yun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apolipoprotein A I promoter; Hepatocellular carcinoma; hTERT; Pegylated immuno lipopolyplexes; RNA interference

Indexed keywords

APOLIPOPROTEIN A1; GREEN FLUORESCENT PROTEIN; LIPOPLEX; NUCLEOTIDYLTRANSFERASE INHIBITOR; PLASMID VECTOR; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CYTOTOXICITY; ENZYME INHIBITION; GENE THERAPY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER TUMOR; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; APOLIPOPROTEIN A-I; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MOLECULAR TARGETED THERAPY; PLASMIDS; TELOMERASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960581539     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.12.036     Document Type: Article

References (26)

1. F.X. Bosch, J. Ribes, M. Diaz, and R. Cleries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 2004 S5 S16
2. L.R. Roberts, and G.J. Gores Hepatocellular carcinoma: molecular pathways and new therapeutic targets Semin. Liver Dis. 12 2005 212 225 (Pubitemid 40781073)
3. A.P. Venook Treatment of hepatocellular carcinoma: too many options? J. Clin. Oncol. 12 1994 1323 1334 (Pubitemid 24173950)
4. S.H. Chen, H.D. Shine, J.C. Goodman, R.G. Grossman, and S.L. Woo Treatment of hepatocellular carcinoma Proc. Natl. Acad. Sci. 91 1994 3054 3057
5. K. Nagao, M. Tomimatsu, H. Endo, H. Hisatomi, and K. Hikiji Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma J. Gastroenterol. 34 1999 83 87 (Pubitemid 29112340)
6. T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, and T.R. Cech Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 999
7. M. Akiyama, O. Yamada, N. Kanda, S. Akita, T. Kawano, T. Ohno, H. Mizoguchi, Y. Eto, K.C. Anderson, and H. Yamada Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors Cancer Lett. 178 2002 187 197 (Pubitemid 34178544)
8. K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M.P. Wirth, and A. Meye Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin. Cancer Res. 9 2003 3794 3800 (Pubitemid 37169250)
9. A. Lechel, M.P. Manns, and K.L. Rudolph Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma J. Hepatol. 41 2004 491 497 (Pubitemid 39158760)
10. W.M. Merritt, M. Bar-Eli, and A.K. Sood The dicey role of Dicer: implications for RNAi therapy Cancer Res. 70 2010 2571 2574
11. N.R. Forsyth, W.E. Wright, and J.W. Shay Telomerase and differentiation in multicelluar organisms: turn it off, turn it on, and turn it off again Differentiation 69 2002 188 197 (Pubitemid 41701542)
12. V.M. Golubovskaya, L.V. Filatov, C.I. Behe, S.C. Presnell, M.J. Hooth, G.J. Smith, and W.K. Kaufmann Telomere shortening, telomerase expression, and chromosome instability in rat hepatic epithelial stem-like cells Mol. Carcinog. 24 1999 209 217 (Pubitemid 29169861)
13. V. Kotoula, P. Hytiroglou, A. Pyrpasopoulou, R. Saxena, S.N. Thung, and C.S. Papadimitriou Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers Liver 22 2002 57 69 (Pubitemid 34552526)
14. Y. Hu, X. Ren, H. Wang, Y. Ma, L. Wang, Y. Shen, K. Oka, Z. Zhang, and Y. Zhang Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter Int. J. Pharm. 398 2010 161 164
15. Y. Hu, K. Li, L. Wang, S. Yin, Z. Zhang, and Y. Zhang Pegylated immuno-lipopolyplexes: a novel non-viral gene delivery system for liver cancer therapy J. Control. Release 144 2010 75 81
16. Y. Zhang, and W.M. Pardridge Delivery of β-galactosidase to mouse brain via the blood-brain barrier transferring receptor J. Pharmacol. Exp. Ther. 313 2005 1075 1081 (Pubitemid 40727011)
17. P.H. Zhang, L. Zou, and Z.G. Tu RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity J. Surg. Res. 131 2006 143 149 (Pubitemid 43227598)
18. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C (T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
19. C. Cerni Telomeres, telomerase, and myc. An update Mutat. Res. 462 2000 31 47 (Pubitemid 30060329)
20. R.X. Lin, C.W. Tuo, Q.J. Lu, W. Zhang, and S.Q. Wang Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model Acta Pharmacol. Sin. 26 2005 762 768 (Pubitemid 40806567)
21. M. Whitemore, S. Li, and L. Huang LPD lipopolyplex inhibits a potent cytokine response and inhibits tumor growth Gene Ther. 6 1999 1867 1875 (Pubitemid 29531282)
22. M. Robbins, A. Judge, E. Ambegia, C. Choi, E. Yaworski, L. Palmer, K. McClintock, and I. MacLachlan Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation Hum. Gene Ther. 19 9 2008 991 999
23. D.D. Rao, J.S. Vorhies, N. Senzer, and J. Nemunaitis siRNA vs. shRNA: similarities and differences Adv. Drug Deliv. Rev. 61 2009 746 759
24. A. Pathak, S.P. Vyas, and K.C. Gupta Nano-vectors for efficient liver specific gene transfer Int. J. Nanomed. 3 2008 31 49 (Pubitemid 351517074)
25. Y. Kohgo, H. Kondo, Y. Mogi, and Y. Niitsu Mechanism and clinical significance of soluble hepatic cell-surface receptors Targeted Diagn. Ther. 4 1991 305 319
26. D. Trere, L. Fiume, L.B. De Giorgi, G. Di Stefano, M. Migaldi, and M. Derenzini The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells Br. J. Cancer 81 1999 404 408 (Pubitemid 29458792)